Zevra Therapeutics Inc

$12.90
Market Cap 757.38M
ROE 81.3%
Gross Margin 94.8%
Debt/Equity 0.0
Current Ratio 4.9
Revenue QoQ 77.5%
EPS QoQ -11.3%
F-Score 4

About

Zevra Therapeutics, Inc. is a commercial-stage rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. Our mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, the Company is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
5.98
vs median 35.63
P/B
3.61
vs median 2.25
ROE
0.81
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics